Copley Acquisition Corp
Copley Acquisition Corp. is a blank check company incorporated in the Cayman Islands. It has no operating business and has limited its activities to organizing the company, conducting its initial public offering and searching for a business combination target. It intends to combine with one or more businesses through a merger, share exchange, asset acquisition, share purchase, reorganization or similar transaction. Copley has not entered into a definitive agreement with a target. Copley may pursue businesses in any industry or region, with a focus on technology and lifestyle sectors, including enabling technology and lifestyle services. It aims to provide a target with capital and expertise, and may use cash, equity, debt or a combination as transaction consideration. It is headquartered in George Town, Cayman Islands.
No SEC Form 4 filings for $COPL in the last 30 days.
See all $COPL insider activity →Copley Acquisition postponed its shareholder meeting to November 2, 2026, to seek approval for extending its business-combination deadline. The company proposed 12 one-month extensions, pushing the deadline to November 2, 2027, and increased the monthly trust contribution to $200,000 from $150,000. Copley also waived certain rights related to trust interest and tax expenses.
Copley Acquisition Corp (COPL) filed an SEC Form 8-K — Other Events. Exhibit 99.1 ANNEX A FORM OF AMENDMENT TO THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF COPLEY ACQUISITION CORP RESOLVED , as a special resolution, that, subject to and conditional upon the passing of the resolution to amend the investment management trust ag
Copley Acquisition (COPL) and Ignite Proteomics mutually terminated their business combination agreement on Oct 9, 2026, with no fees or payments exchanged. Both parties will bear their own expenses. Copley plans to pursue alternative business combinations before its Nov 2, 2026 deadline.
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning COPL (Copley Acquisition Corp). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.
Recent COPL coverage spans corporate actions and mergers & acquisitions.
The extension and higher contribution may dilute existing shareholders and delay the business combination, likely weighing on the stock.
The amendment may increase uncertainty around the business‑combination timeline, potentially pressuring the share price.
Termination removes the proposed merger path and increases uncertainty around Copley’s next alternative deal before its Nov. 2, 2026 deadline.
Termination of the SPAC deal increases liquidation and redemption risk and shifts the focus to finding a replacement target before the Nov. 2, 2026 deadline.
The sponsor financing terms expand near-term liquidity for the SPAC while keeping conversion economics tied to $7.00 per unit.
AlphAI scores every news story that mentions COPL with an AI model for sentiment and relevance, and aggregates insider trades from Copley Acquisition Corp's SEC EDGAR Form 4 filings. Figures refresh continuously.
Copley Acquisition postponed its shareholder meeting to November 2, 2026, to seek approval for extending its business-combination deadline. The company proposed 12 one-month extensions, pushing the deadline to November 2, 2027, and increased the monthly trust contribution to $200,000 from $150,000. Copley also waived certain rights related to trust interest and tax expenses.
1 min readCopley Acquisition Corp (COPL) filed an SEC Form 8-K — Other Events. Exhibit 99.1 ANNEX A FORM OF AMENDMENT TO THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF COPLEY ACQUISITION CORP RESOLVED , as a special resolution, that, subject to and conditional upon the passing of the resolution to amend the investment management trust ag
1 min readCopley Acquisition (COPL) and Ignite Proteomics mutually terminated their business combination agreement on Oct 9, 2026, with no fees or payments exchanged. Both parties will bear their own expenses. Copley plans to pursue alternative business combinations before its Nov 2, 2026 deadline.
1 min readCopley Acquisition Corp (COPL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry Into a Material Definitive Agreement. The information set forth in Item 1.02 below is hereby incorporated by reference into this Item 1.01. Item 1.02 Termination of a Material Definitive Agreement. As previously disclosed, on June 10, 2026, Copley Acquisition Corp
4 min readCopley Acquisition amended a convertible note with its sponsor, increasing funding to $900,000 for working capital. The note is interest-free and repayable at the earlier of a business combination or liquidation. The sponsor can convert amounts into units at $7.00 per unit, each including one share and a half warrant. Repayment, if no combination occurs, comes from non-trust funds. According to the company, the agreement was signed on October 6, 2026.
1 min readCopley Acquisition Corp (COPL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On October 6, 2026, Copley Acquisition Corp (“COPL”) issued to Copley Acquisition Sponsors LLC (“Sponsor”) an amended and restated convertible promissory note (the “Note”). The Note amends and restates in its entirety that cer
4 min readCopley Acquisition Corp (NYSE: COPL) and Ignite Proteomics announced a definitive business combination agreement to create a new NYSE-listed public holding company, intended to be named Ignite Proteomics Holdings, Inc. The deal is expected to close in the second half of 2026, subject to customary conditions. The companies cite a $150 million pro forma enterprise value.
4 min readCopley Acquisition Corp (COPL) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-2.1 2 copleyacq_ex2-1.htm EXHIBIT 2.1 Exhibit 2.1 BUSINESS COMBINATION AGREEMENT by and among Copley Acquisition Corp , as SPAC, Ignite Proteomics Holdings, Inc., as Pubco, Ignite Merger Sub I Inc., as SPAC Merger Sub, Ignite Merger Sub II LLC , as Company Merger Sub, Jeffrey
6 min read
